rs386833920
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_004646.4(NPHS1):c.2596C>T(p.Arg866*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000617 in 1,459,810 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_004646.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000815 AC: 2AN: 245462Hom.: 0 AF XY: 0.0000151 AC XY: 2AN XY: 132802
GnomAD4 exome AF: 0.00000617 AC: 9AN: 1459810Hom.: 0 Cov.: 33 AF XY: 0.00000826 AC XY: 6AN XY: 726018
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Finnish congenital nephrotic syndrome Pathogenic:5
- -
- -
- -
- -
Variant summary: NPHS1 c.2596C>T (p.Arg866X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 8.1e-06 in 245462 control chromosomes. c.2596C>T has been reported in the literature in at-least one individual affected with Nephrotic Syndrome, Type 1 and has been subsequently cited by others (example, Heeringa_2008, Lovric_2014, Sadowski_2015, Machuca_2010). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic (n=2)/likely pathogenic (n=1). Based on the evidence outlined above, the variant was classified as pathogenic. -
See cases Pathogenic:1
ACMG classification criteria: PVS1, PS4, PM2 -
not provided Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg866*) in the NPHS1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NPHS1 are known to be pathogenic (PMID: 11317351, 11854170, 12039988). This variant is present in population databases (rs386833920, gnomAD 0.002%). This premature translational stop signal has been observed in individual(s) with congenital nephrotic syndrome (PMID: 18503012). ClinVar contains an entry for this variant (Variation ID: 56481). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Nephrotic syndrome Pathogenic:1
This patient is heterozygous for a known pathogenic variant, c.2596C>T, in the NPHS1 gene. This variant (dbSNP: rs386833920) creates a premature stop codon (p.Arg866*), and may result in a null allele due to nonsense-mediated mRNA decay. This variant has been previously reported in a compound heterozygote with another pathogenic NPHS1 variant in a two month old child with congenital nephrotic syndrome (Heeringa et al 2008 Nephrol Dial Transplant 23:3527-3533). This variant is considered to be a pathogenic according to the ACMG guidelines -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at